Asciminib Roll-over Study
Condition: Chronic Myelogenous Leukemia Interventions: Drug: Asciminib single agent; Drug: Asciminib; Drug: Imatinib; Drug: Nilotinib; Drug: Bosutinib; Procedure: ECG; Procedure: Pregnancy test Sponsor: Novartis Pharmaceuticals Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials